查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1831767

CRISPR與Cas遺傳基因市場，規模，佔有率，趨勢，產業分析報告:各產品，各類服務，各用途，各最終用途，各地區 - 2025年～2034年的市場預測

CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，CRISPR 和 Cas 基因市場規模將達到 214.6 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

CRISPR 和 Cas 基因是指用於基因編輯的天然細菌防禦系統。 CRISPR 序列引導 Cas 酶到達特定的 DNA 位置，從而實現精確切割。

CRISPR 基因編輯提供了一種可持續的農作物改良方法，以應對日益增長的糧食需求和環境挑戰。 CRISPR 無需外源基因即可培育抗蟲、耐旱和高產量的植物。這種精準技術有助於培育出比傳統基因改造生物 (GMO) 更健康、更有營養、更受消費者和監管機構歡迎的作物。各國政府和農業公司正在大力投資以 CRISPR 為基礎的作物研究，以提高糧食安全。基因編輯在農業領域的應用日益廣泛，極大地推動了對 CRISPR 酶、試劑盒和試劑的需求，從而推動了全球市場的成長。

個人化醫療專注於根據個體獨特的基因特徵客製化治療方案。 CRISPR 技術對於開發針對特定致病基因突變的基因療法至關重要。隨著人們對遺傳疾病認識的不斷提高，越來越多的患者正在尋求個人化治療，以提高療效並減少副作用。這一趨勢推動了對基於 CRISPR 的診斷和治療的需求，鼓勵公司投資研發和產品開發。基因編輯能夠為癌症、罕見疾病和遺傳性疾病創建客製化解決方案，隨著個人化醫療成為 CRISPR 和 Cas 基因市場的主要驅動力，市場正在不斷擴大。

CRISPR 和 Cas 基因市場報告重點

由於試劑盒和酵素在促進基因編輯過程中發揮至關重要的作用，因此預計在預測期內，其複合年增長率將達到 19.1%。

2024 年，農業應用領域佔市場收入的 13.11%。這得歸功於對改良作物性狀（例如抗蟲、耐旱和高產）日益增長的需求，這些性狀是應對全球糧食安全挑戰的重要解決方案。

2024 年，北美將引領 CRISPR 和 Cas 基因市場，佔全球收入的 45.52%，這得益於其強大的研究生態系統、雄厚的資金支持和高度發達的生物技術部門。

受生物技術研究投資增加和醫療基礎設施加強的推動，亞太地區 CRISPR 和 Cas 基因市場預計在預測期內以 19.3% 的複合年增長率擴張。

全球主要市場參與者包括 Addgene、阿斯特捷利康、Caribou Biosciences, Inc.、Cellectis、CRISPR Therapeutics、丹納赫集團、Editas Medicine, Inc.、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England；和 Sherlock Biosciences。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 CRISPR和Cas遺傳基因市場洞察

  • CRISPR和Cas遺傳基因 - 產業概述
  • CRISPR和Cas遺傳基因市場動態
    • 促進因素和機會
      • CRISPR 技術創新
      • 在各領域的應用
    • 限制因素和挑戰
      • 固有缺陷
  • PEST 分析
  • CRISPR 和 Cas 基因市場產業趨勢
  • COVID-19 的影響分析

第5章 聯絡處資訊

  • 取得技術許可的聯絡方式
    • Wellcome Trust Sanger Institute, Cambridge, UK
    • The Innovative Genomics Initiative, California
    • Thermo Fisher Scientific, Waltham, Massachusetts
    • the Broad Institute and Whitehead Institute
    • ERS Genomics Ltd
    • Merck KGaA
    • Oxford Genetics Limited
    • Caribou Biosciences, Inc.
    • CRISPR Therapeutics
    • Sherlock Biosciences
    • US Berkeley
  • 基因編輯技術的契約金額

第6章 CRISPR與Cas遺傳基因市場評估:各產品及服務

  • 簡介
  • 產品
  • 服務

第7章 CRISPR與Cas遺傳基因市場評估:各用途

  • 簡介
  • 生物醫學
  • 農業

第8章 CRISPR與Cas遺傳基因市場評估:各最終用途

  • 簡介
  • 生物科技及製藥公司
  • 學術機構及政府調查機關
  • 契約調查機關(CRO)

第9章 CRISPR與Cas遺傳基因市場評估:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章 競爭情形

  • 產品銷售和合作，是被企業最僱用的策略。
  • 產品銷售
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Addgene
  • AstraZeneca
  • Caribou Biosciences, Inc.
  • Cellectis
  • CRISPR Therapeutics
  • Danaher Corporation
  • Editas Medicine, Inc.
  • Horizon Discovery Group Plc
  • Mammoth Biosciences
  • New England BioLabs
Product Code: PM1738

The CRISPR & cas genes market size is expected to reach USD 21.46 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

CRISPR-Cas genes refer to a natural bacterial defense system used for gene editing. The CRISPR sequences guide the Cas enzyme to specific DNA locations to make precise cuts.

CRISPR gene editing offers a sustainable way to improve crops with increasing food demand and environmental challenges. It enables the development of pest-resistant, drought-tolerant, and higher-yielding plants without introducing foreign genes. This precision technology helps create healthier, more nutritious crops that meet consumer and regulatory preferences better than traditional genetically modified organisms (GMOs). Governments and agricultural companies invest heavily in CRISPR-based crop research to improve food security. The expanding use of gene editing in agriculture significantly boosts the demand for CRISPR enzymes, kits, and reagents, driving the market's growth worldwide.

Personalized medicine focuses on tailoring treatments based on an individual's unique genetic profile. CRISPR technology is crucial for developing gene therapies that target specific genetic mutations causing diseases. More patients seek personalized treatments that improve effectiveness and reduce side effects as awareness about genetic disorders rises. This trend fuels demand for CRISPR-based diagnostics and therapeutics, encouraging companies to invest in research and product development. The market grows as gene editing enables the creation of customized solutions for cancer, rare diseases, and inherited conditions, making personalized medicine a key driver in the CRISPR & Cas genes market.

CRISPR & Cas Genes Market Report Highlights

The kits & enzymes segment is projected to register a CAGR of 19.1% during the forecast period, owing to their essential role in facilitating gene-editing processes.

In 2024, the agricultural application segment captured 13.11% of the market revenue, driven by rising demand for improved crop traits such as pest resistance, drought tolerance, and higher yield, which is a key solution to global food security challenges.

North America led the CRISPR & Cas genes market in 2024, accounting for 45.52% of the global revenue, supported by a robust research ecosystem, significant financial backing, and a highly developed biotechnology sector.

The Asia Pacific CRISPR & Cas genes market is anticipated to expand at a CAGR of 19.3% during the forecast period, fueled by growing investments in biotechnology research and the strengthening of healthcare infrastructure.

A few global key market players are Addgene, AstraZeneca, Caribou Biosciences, Inc., Cellectis, CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Horizon Discovery Group Plc, Mammoth Biosciences, New England BioLabs, Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, Thermo Fisher Scientific, ERS Genomics Ltd, Merck KGaA, Oxford Genetics Limited, and Sherlock Biosciences.

Polaris Market Research has segmented the CRISPR & Cas genes market report based on product, service, application, end use, and region:

By Product (Revenue - USD Billion, 2020-2034)

Kits & Enzymes

Vector-Based Cas

DNA-Free Cas

Libraries

Design Tool

Antibodies

Other Products

By Service (Revenue - USD Billion, 2020-2034)

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA Synthesis

By Application (Revenue - USD Billion, 2020-2034)

Biomedical

Agricultural

By End Use (Revenue - USD Billion, 2020-2034)

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objectives of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

  • 3.1 Overview
    • 3.1.1 Data Mining
  • 3.2 Data Sources
    • 3.2.1 Primary Sources
    • 3.2.2 Secondary Sources

Chapter 4. CRISPR & Cas Genes Market Insights

  • 4.1 CRISPR & Cas Genes - Industry snapshot
  • 4.1 CRISPR & Cas Genes Market Dynamics
    • 4.1.1 Drivers and Opportunities
      • 4.1.1.1 Innovations in CRISPR technologies
      • 4.1.1.2 Applicability in varied areas
    • 4.1.2 Restraints and Challenges
      • 4.1.2.1 Inherent Disadvantages
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers (Moderate)
    • 4.2.2 Threats of New Entrants: (Low)
    • 4.2.3 Bargaining Power of Buyers (Low to Medium)
    • 4.2.4 Threat of Substitute (Low)
    • 4.2.5 Rivalry among existing firms (Medium to High)
  • 4.3 PEST Analysis
  • 4.4 CRISPR & Cas Genes Market Industry trends
  • 4.5 COVID-19 Impact Analysis

Chapter 5. Contact Point Information

  • 5.1 Contact Point Information for obtaining a license to use the technology
    • 5.1.1 Wellcome Trust Sanger Institute, Cambridge, UK
    • 5.1.2 The Innovative Genomics Initiative, California
    • 5.1.3 Thermo Fisher Scientific, Waltham, Massachusetts
    • 5.1.4 the Broad Institute and Whitehead Institute
    • 5.1.5 ERS Genomics Ltd
    • 5.1.6 Merck KGaA
    • 5.1.7 Oxford Genetics Limited
    • 5.1.8 Caribou Biosciences, Inc.
    • 5.1.9 CRISPR Therapeutics
    • 5.1.10 Sherlock Biosciences
    • 5.1.11 UC Berkeley
  • 5.2 The contract amount for genome editing technology

Chapter 6. CRISPR & Cas Genes Market Assessment by Product & Services

  • 6.1 Introduction
  • 6.2 Product
    • 6.2.1 Kits & Enzymes
      • 6.2.1.1 Vector-based Cas
      • 6.2.1.2 DNA-free Cas
    • 6.2.2 Libraries
    • 6.2.3 Design Tool
    • 6.2.5 Other Products
  • 6.3 Services
    • 6.3.1 Cell Line Engineering
    • 6.3.2 gRNA Design
    • 6.3.3 Microbial Gene Editing
    • 6.3.4 DNA Synthesis

Chapter 7. CRISPR & Cas Genes Market Assessment by Application

  • 7.1 Introduction
  • 7.2 Biomedical
  • 7.3 Agricultural

Chapter 8. CRISPR & Cas Genes Market Assessment by End-Use

  • 8.1 Introduction
  • 8.2 Biotechnology & Pharmaceutical Companies
  • 8.3 Academics & Government Research Institutes
  • 8.4 Contract Research Organizations (CROs)

Chapter 9. CRISPR & Cas Genes Market Assessment by Region

  • 9.1 Introduction
  • 9.2 CRISPR & Cas Genes Market - North America
    • 9.2.1 CRISPR & Cas Genes Market - U.S.
    • 9.2.2 CRISPR & Cas Genes Market - Canada
  • 9.3 CRISPR & Cas Genes Market - Europe
    • 9.3.1 CRISPR & Cas Genes Market - Germany
    • 9.3.2 CRISPR & Cas Genes Market - UK
    • 9.3.3 CRISPR & Cas Genes Market - France
    • 9.3.4 CRISPR & Cas Genes Market - Italy
    • 9.3.5 CRISPR & Cas Genes Market - Spain
    • 9.3.6 CRISPR & Cas Genes Market - Netherlands
    • 9.3.7 CRISPR & Cas Genes Market - Austria
  • 9.4 CRISPR & Cas Genes Market - Asia Pacific
    • 9.4.1 CRISPR & Cas Genes Market - China
    • 9.4.2 CRISPR & Cas Genes Market - India
    • 9.4.3 CRISPR & Cas Genes Market - Japan
    • 9.4.4 CRISPR & Cas Genes Market - South Korea
  • 9.5 CRISPR & Cas Genes Market - Latin America
    • 9.5.1 CRISPR & Cas Genes Market - Brazil
    • 9.5.2 CRISPR & Cas Genes Market - Mexico
    • 9.5.3 CRISPR & Cas Genes Market - Argentina
  • 9.6 CRISPR & Cas Genes Market - Middle East & Africa
    • 9.6.1 CRISPR & Cas Genes Market - Saudi Arabia
    • 9.6.2 CRISPR & Cas Genes Market - UAE

Chapter 10. Competitive Landscape

  • 10.1 Product Launch & Collaborations Both Are The Best Adopted Strategies by the Companies
  • 10.2 Product Launch
  • 10.3 Partnerships/Collaborations/Agreements/Exhibitions

Chapter 11. The Company Profiles

  • 11.1 Addgene
    • 11.1.1 Business Overview
    • 11.1.2 Financial Snapshot
    • 11.1.3 Products and Services
  • 11.2 AstraZeneca
    • 11.2.1 Business Overview
    • 11.2.2 Financial Snapshot
    • 11.2.3 Products and Services
    • 11.2.4 Recent Developments
  • 11.3 Caribou Biosciences, Inc.
    • 11.3.1 Business Overview
    • 11.3.2 Financial Snapshot
    • 11.3.3 Products and Services
    • 11.3.4 Recent Developments
  • 11.4 Cellectis
    • 11.4.1 Business Overview
    • 11.4.2 Financial Snapshot
    • 11.4.3 Products and Services
    • 11.4.4 Recent Developments
  • 11.5 CRISPR Therapeutics
    • 11.5.1 Business Overview
    • 11.5.2 Financial Snapshot
    • 11.5.3 Products and Services
    • 11.5.4 Recent Developments
  • 11.6 Danaher Corporation
    • 11.6.1 Business Overview
    • 11.6.2 Financial Snapshot
    • 11.6.3 Products and Services
    • 11.6.4 Recent Developments
  • 11.7 Editas Medicine, Inc.
    • 11.7.1 Business Overview
    • 11.7.2 Financial Snapshot
    • 11.7.3 Products and Services
  • 11.8 Horizon Discovery Group Plc
    • 11.8.1 Business Overview
    • 11.8.2 Financial Snapshot
    • 11.8.3 Products and Services
    • 11.8.4 Recent Developments
  • 11.9 Mammoth Biosciences
    • 11.9.1 Business Overview
    • 11.9.2 Financial Snapshot
    • 11.9.3 Products and Services
  • 11.10 New England BioLabs
    • 11.10.1 Business Overview
    • 11.10.2 Financial Snapshot
    • 11.10.3 Products and Services
  • Table 1 Contact Details: Wellcome Trust Sanger Institute
  • Table 2 Contact Details : The Innovative Genomics Initiative, California
  • Table 3 Contact Details : Thermo Fisher Scientific
  • Table 4 Contact Details : the Broad Institute and Whitehead Institute
  • Table 5 Contact Details : ERS Genomics Ltd
  • Table 6 Contact Details : Merck KGaA
  • Table 7 Contact Details : Oxford Genetics Limited
  • Table 8 Contact Details : Caribou Biosciences, Inc.
  • Table 9 Contact Details : CRISPR Therapeutics
  • Table 10 Contact Details : Sherlock Biosciences
  • Table 11 Contact Details : UC Berkeley
  • Table 12 Global CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 13 Global CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 14 Global CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 15 Global CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 16 Global CRISPR & Cas Genes Market, by Product, 2020 - 2034 (USD Million)
  • Table 17 Global CRISPR & Cas Genes Market, by Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 18 Global CRISPR & Cas Genes Market, by Vector-based Cas, 2020 - 2034 (USD Million)
  • Table 19 Global CRISPR & Cas Genes Market, by DNA-free Cas, 2020 - 2034 (USD Million)
  • Table 20 Global CRISPR & Cas Genes Market, by Libraries, 2020 - 2034 (USD Million)
  • Table 21 Global CRISPR & Cas Genes Market, by Design Tool, 2020 - 2034 (USD Million)
  • Table 22 Global CRISPR & Cas Genes Market, by Antibodies, 2020 - 2034 (USD Million)
  • Table 23 Global CRISPR & Cas Genes Market, by Other Products, 2020 - 2034 (USD Million)
  • Table 24 Global CRISPR & Cas Genes Market, by Services, 2020 - 2034 (USD Million)
  • Table 25 Global CRISPR & Cas Genes Market, by Cell Line Engineering, 2020 - 2034 (USD Million)
  • Table 26 Global CRISPR & Cas Genes Market, by gRNA Design, 2020 - 2034 (USD Million)
  • Table 27 Global CRISPR & Cas Genes Market, by Microbial Gene Editing, 2020 - 2034 (USD Million)
  • Table 28 Global CRISPR & Cas Genes Market, by DNA Synthesis, 2020 - 2034 (USD Million)
  • Table 29 Global CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 30 Global CRISPR & Cas Genes Market, by Biomedical, 2020 - 2034 (USD Million)
  • Table 31 Global CRISPR & Cas Genes Market, by Agricultural, 2020 - 2034 (USD Million)
  • Table 32 Global CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 33 Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, 2020 - 2034 (USD Million)
  • Table 34 Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, 2020 - 2034 (USD Million)
  • Table 35 Global CRISPR & Cas Genes Market, by Contract Research Organizations (CROs), 2020 - 2034 (USD Million)
  • Table 36 CRISPR & Cas Genes Market Assessment, By Geography, 2020 - 2034 (USD Million)
  • Table 37 North America CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 38 North America CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 39 North America CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 40 North America CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 41 North America CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 42 North America CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 43 U.S. CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 44 U.S. CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 45 U.S. CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 46 U.S. CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 47 U.S. CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 48 U.S. CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 49 Canada CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 50 Canada CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 51 Canada CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 52 Canada CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 53 Canada CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 54 Canada CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 55 Europe CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 56 Europe CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 57 Europe CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 58 Europe CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 59 Europe CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 60 Europe CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 61 Germany CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 62 Germany CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 63 Germany CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 64 Germany CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 65 Germany CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 66 Germany CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 67 UK CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 68 UK CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 69 UK CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 70 UK CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 71 UK CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 72 UK CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 73 France CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 74 France CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 75 France CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 76 France CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 77 France CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 78 France CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 79 Italy CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 80 Italy CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 81 Italy CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 82 Italy CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 83 Italy CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 84 Italy CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 85 Spain CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 86 Spain CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 87 Spain CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 88 Spain CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 89 Spain CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 90 Spain CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 91 Netherlands CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 92 Netherlands CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 93 Netherlands CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 94 Netherlands CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 95 Netherlands CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 96 Netherlands CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 97 Austria CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 98 Austria CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 99 Austria CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 100 Austria CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 101 Austria CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 102 Austria CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 103 Asia Pacific CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 104 Asia Pacific CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 105 Asia Pacific CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 106 Asia Pacific CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 107 Asia Pacific CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 108 Asia Pacific CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 109 China CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 110 China CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 111 China CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 112 China CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 113 China CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 114 China CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 115 India CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 116 India CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 117 India CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 118 India CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 119 India CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 120 India CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 121 Japan CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 122 Japan CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 123 Japan CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 124 Japan CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 125 Japan CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 126 Japan CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 127 South Korea CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 128 South Korea CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 129 South Korea CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 130 South Korea CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 131 South Korea CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 132 South Korea CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 133 Latin America CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 134 Latin America CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 135 Latin America CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 136 Latin America CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 137 Latin America CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 138 Latin America CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 139 Brazil CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 140 Brazil CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 141 Brazil CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 142 Brazil CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 143 Brazil CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 144 Brazil CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 145 Mexico CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 146 Mexico CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 147 Mexico CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 148 Mexico CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 149 Mexico CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 150 Mexico CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 151 Argentina CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 152 Argentina CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 153 Argentina CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 154 Argentina CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 155 Argentina CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 156 Argentina CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 157 Middle East & Africa CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 158 Middle East & Africa CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 159 Middle East & Africa CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 160 Middle East & Africa CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 161 Middle East & Africa CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 162 Middle East & Africa CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 163 Saudi Arabia CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 164 Saudi Arabia CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 165 Saudi Arabia CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 166 Saudi Arabia CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 167 Saudi Arabia CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 168 Saudi Arabia CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 169 UAE CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 170 UAE CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 171 UAE CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 172 UAE CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 173 UAE CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 174 UAE CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Figure 1. Executive Summary
  • Figure 2. Research Methodology: Top Down & Bottom-Up Approach
  • Figure 3. Market by Geography, 2017 - 2028 (USD Million)
  • Figure 4. Porter's Five Forces
  • Figure 5. PEST Analysis
  • Figure 6. Market by Product & Services
  • Figure 7. Global CRISPR & Cas Genes Market, By Product & Services, 2020 & 2028 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global CRISPR & Cas Genes Market, By Application, 2020 & 2028 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global CRISPR & Cas Genes Market, By End-Use, 2020 & 2028 (USD Million)
  • Figure 12. CRISPR & Cas Genes Market Assessment, By Geography, 2020 & 2028 (USD Million)
  • Figure 13. Strategic Analysis - CRISPR & Cas Genes